CRON
Cronos Group Inc.
Drug Manufacturers - Specialty & Generic
Market Cap$1000M
5Y Perf.-59.9%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CRON vs PM
Revenue, margins, valuation, and 5-year total return — side by side.
PM
Philip Morris International Inc.
Tobacco
Market Cap$265.78B
5Y Perf.+132.5%
CRON vs PM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CRON | PM |
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Tobacco |
| Market Cap | $1000M | $265.78B |
| Revenue (TTM) | $193M | $41.49B |
| Net Income (TTM) | $-9M | $11.10B |
| Gross Margin | 32.5% | 67.3% |
| Operating Margin | -1.5% | 36.8% |
| Forward P/E | 34.9x | 20.3x |
| Total Debt | $2M | $48.84B |
| Cash & Equiv. | $792M | $4.87B |
CRON vs PM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CRON
PM
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cronos Group Inc. (CRON) | 100 | 40.1 | -59.9% |
| Philip Morris Inter… (PM) | 100 | 232.5 | +132.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRON vs PM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: PM leads in 4 of 6 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Cronos Group Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CRON
Cronos Group Inc.
The Growth Play
CRON is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 64.4%, EPS growth -100.0%, 3Y rev CAGR 30.6%
- 14.9% 10Y total return vs PM's 118.5%
- Lower volatility, beta 0.98, Low D/E 0.1%, current ratio 19.59x
Best for: growth exposure and long-term compounding
PM
Philip Morris International Inc.
The Value Play
PM carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (20.3x vs 34.9x)
- 26.7% margin vs CRON's -4.9%
- 3.2% yield; 16-year raise streak; the other pay no meaningful dividend
Best for: value and quality
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CRON | 64.4% revenue growth vs PM's 7.3% |
| Value | PM | Lower P/E (20.3x vs 34.9x) |
| Quality / Margins | PM | 26.7% margin vs CRON's -4.9% |
| Dividends | PM | 3.2% yield; 16-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | CRON | +41.6% vs PM's +1.3% |
| Efficiency (ROA) | PM | 16.2% ROA vs CRON's -0.8%, ROIC 33.2% vs -0.8% |
CRON vs PM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
CRON vs PM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLPMLAGGINGCRON
CRONCronos Group Inc.
0leads
PMPhilip Morris Interna…
4leads
6 Total Categories
CATEGORYLEADERvs CRONMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
PM5/6
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
PM4/6
Total Returns1Y, 3Y, 5Y total returns with dividends
PM4/6
Risk & VolatilityBeta, volatility, and downside exposure
PM2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
PM leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PM is the larger business by revenue, generating $41.5B annually — 214.6x CRON's $193M. PM is the more profitable business, keeping 26.7% of every revenue dollar as net income compared to CRON's -4.9%. On growth, CRON holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CRONCronos Group Inc. | PMPhilip Morris Int… |
|---|---|---|
| RevenueTrailing 12 months | $193M | $41.5B |
| EBITDAEarnings before interest/tax | -$810,000 | $17.2B |
| Net IncomeAfter-tax profit | -$9M | $11.1B |
| Free Cash FlowCash after capex | -$163,766 | $10.7B |
| Gross MarginGross profit ÷ Revenue | +32.5% | +67.3% |
| Operating MarginEBIT ÷ Revenue | -1.5% | +36.8% |
| Net MarginNet income ÷ Revenue | -4.9% | +26.7% |
| FCF MarginFCF ÷ Revenue | -0.1% | +25.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +9.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | -9.3% |
PM leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
Evenly matched — CRON and PM each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | CRONCronos Group Inc. | PMPhilip Morris Int… |
|---|---|---|
| Market CapShares × price | $1000M | $265.8B |
| Enterprise ValueMkt cap + debt − cash | $209M | $309.7B |
| Trailing P/EPrice ÷ TTM EPS | — | 23.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.93x | 20.31x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.32x |
| EV / EBITDAEnterprise value multiple | — | 18.30x |
| Price / SalesMarket cap ÷ Revenue | 5.17x | 6.54x |
| Price / BookPrice ÷ Book value/share | 0.91x | — |
| Price / FCFMarket cap ÷ FCF | — | 24.92x |
Evenly matched — CRON and PM each lead in 1 of 2 comparable metrics.
Profitability & Efficiency
PM leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), PM scores 7/9 vs CRON's 6/9, reflecting strong financial health.
| Metric | CRONCronos Group Inc. | PMPhilip Morris Int… |
|---|---|---|
| ROE (TTM)Return on equity | -0.9% | — |
| ROA (TTM)Return on assets | -0.8% | +16.2% |
| ROICReturn on invested capital | -0.8% | +33.2% |
| ROCEReturn on capital employed | -0.3% | +36.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.00x | — |
| Net DebtTotal debt minus cash | -$790M | $44.0B |
| Cash & Equiv.Liquid assets | $792M | $4.9B |
| Total DebtShort + long-term debt | $2M | $48.8B |
| Interest CoverageEBIT ÷ Interest expense | — | 10.25x |
PM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
PM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PM five years ago would be worth $20,328 today (with dividends reinvested), compared to $3,438 for CRON. Over the past 12 months, CRON leads with a +41.6% total return vs PM's +1.3%. The 3-year compound annual growth rate (CAGR) favors PM at 25.0% vs CRON's 9.6% — a key indicator of consistent wealth creation.
| Metric | CRONCronos Group Inc. | PMPhilip Morris Int… |
|---|---|---|
| YTD ReturnYear-to-date | -3.0% | +7.3% |
| 1-Year ReturnPast 12 months | +41.6% | +1.3% |
| 3-Year ReturnCumulative with dividends | +31.7% | +95.5% |
| 5-Year ReturnCumulative with dividends | -65.6% | +103.3% |
| 10-Year ReturnCumulative with dividends | +1487.9% | +118.5% |
| CAGR (3Y)Annualised 3-year return | +9.6% | +25.0% |
PM leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
PM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PM is the less volatile stock with a -0.07 beta — it tends to amplify market swings less than CRON's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PM currently trades 89.1% from its 52-week high vs CRON's 76.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CRONCronos Group Inc. | PMPhilip Morris Int… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | -0.07x |
| 52-Week HighHighest price in past year | $3.43 | $191.30 |
| 52-Week LowLowest price in past year | $1.83 | $142.11 |
| % of 52W HighCurrent price vs 52-week peak | +76.4% | +89.1% |
| RSI (14)Momentum oscillator 0–100 | 50.0 | 57.0 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 4.6M |
PM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CRON as "Hold" and PM as "Buy". Consensus price targets imply 10.0% upside for PM (target: $188) vs -12.2% for CRON (target: $2). PM is the only dividend payer here at 3.25% yield — a key consideration for income-focused portfolios.
| Metric | CRONCronos Group Inc. | PMPhilip Morris Int… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $2.30 | $187.60 |
| # AnalystsCovering analysts | 15 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +3.2% |
| Dividend StreakConsecutive years of raises | — | 16 |
| Dividend / ShareAnnual DPS | — | $5.54 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
PM leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.
Best OverallPhilip Morris International… (PM)Leads 4 of 6 categories
Loading custom metrics...
CRON vs PM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CRON or PM a better buy right now?
For growth investors, Cronos Group Inc.
(CRON) is the stronger pick with 64. 4% revenue growth year-over-year, versus 7. 3% for Philip Morris International Inc. (PM). Philip Morris International Inc. (PM) offers the better valuation at 23. 5x trailing P/E (20. 3x forward), making it the more compelling value choice. Analysts rate Philip Morris International Inc. (PM) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CRON or PM?
On forward P/E, Philip Morris International Inc.
is actually cheaper at 20. 3x.
03Which is the better long-term investment — CRON or PM?
Over the past 5 years, Philip Morris International Inc.
(PM) delivered a total return of +103. 3%, compared to -65. 6% for Cronos Group Inc. (CRON). Over 10 years, the gap is even starker: CRON returned +1488% versus PM's +118. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CRON or PM?
By beta (market sensitivity over 5 years), Philip Morris International Inc.
(PM) is the lower-risk stock at -0. 07β versus Cronos Group Inc. 's 0. 98β — meaning CRON is approximately -1544% more volatile than PM relative to the S&P 500.
05Which is growing faster — CRON or PM?
By revenue growth (latest reported year), Cronos Group Inc.
(CRON) is pulling ahead at 64. 4% versus 7. 3% for Philip Morris International Inc. (PM). On earnings-per-share growth, the picture is similar: Philip Morris International Inc. grew EPS 60. 6% year-over-year, compared to -100. 0% for Cronos Group Inc.. Over a 3-year CAGR, CRON leads at 30. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CRON or PM?
Philip Morris International Inc.
(PM) is the more profitable company, earning 27. 9% net margin versus -4. 9% for Cronos Group Inc. — meaning it keeps 27. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PM leads at 36. 7% versus -1. 5% for CRON. At the gross margin level — before operating expenses — PM leads at 67. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CRON or PM more undervalued right now?
On forward earnings alone, Philip Morris International Inc.
(PM) trades at 20. 3x forward P/E versus 34. 9x for Cronos Group Inc. — 14. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PM: 10. 0% to $187. 60.
08Which pays a better dividend — CRON or PM?
In this comparison, PM (3.
2% yield) pays a dividend. CRON does not pay a meaningful dividend and should not be held primarily for income.
09Is CRON or PM better for a retirement portfolio?
For long-horizon retirement investors, Philip Morris International Inc.
(PM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 07), 3. 2% yield, +118. 5% 10Y return). Both have compounded well over 10 years (PM: +118. 5%, CRON: +1488%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CRON and PM?
These companies operate in different sectors (CRON (Healthcare) and PM (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CRON is a small-cap high-growth stock; PM is a large-cap income-oriented stock. PM pays a dividend while CRON does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CRON: 201.3% · PM: 9.1%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.